Cargando…

Applications of machine learning in decision analysis for dose management for dofetilide

BACKGROUND: Initiation of the antiarrhythmic medication dofetilide requires an FDA-mandated 3 days of telemetry monitoring due to heightened risk of toxicity within this time period. Although a recommended dose management algorithm for dofetilide exists, there is a range of real-world approaches to...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Andrew E., Biswas, Minakshi, Weber, Rachel, Tarakji, Khaldoun, Chung, Mina, Noseworthy, Peter A., Newton-Cheh, Christopher, Rosenberg, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938356/
https://www.ncbi.nlm.nih.gov/pubmed/31891645
http://dx.doi.org/10.1371/journal.pone.0227324
_version_ 1783484023523246080
author Levy, Andrew E.
Biswas, Minakshi
Weber, Rachel
Tarakji, Khaldoun
Chung, Mina
Noseworthy, Peter A.
Newton-Cheh, Christopher
Rosenberg, Michael A.
author_facet Levy, Andrew E.
Biswas, Minakshi
Weber, Rachel
Tarakji, Khaldoun
Chung, Mina
Noseworthy, Peter A.
Newton-Cheh, Christopher
Rosenberg, Michael A.
author_sort Levy, Andrew E.
collection PubMed
description BACKGROUND: Initiation of the antiarrhythmic medication dofetilide requires an FDA-mandated 3 days of telemetry monitoring due to heightened risk of toxicity within this time period. Although a recommended dose management algorithm for dofetilide exists, there is a range of real-world approaches to dosing the medication. METHODS AND RESULTS: In this multicenter investigation, clinical data from the Antiarrhythmic Drug Genetic (AADGEN) study was examined for 354 patients undergoing dofetilide initiation. Univariate logistic regression identified a starting dofetilide dose of 500 mcg (OR 5.0, 95%CI 2.5–10.0, p<0.001) and sinus rhythm at the start of dofetilide loading (OR 2.8, 95%CI 1.8–4.2, p<0.001) as strong positive predictors of successful loading. Any dose-adjustment during loading (OR 0.19, 95%CI 0.12–0.31, p<0.001) and a history coronary artery disease (OR 0.33, 95%CI 0.19–0.59, p<0.001) were strong negative predictors of successful dofetilide loading. Based on the observation that any dose adjustment was a significant negative predictor of successful initiation, we applied multiple supervised approaches to attempt to predict the dose adjustment decision, but none of these approaches identified dose adjustments better than a probabilistic guess. Principal component analysis and cluster analysis identified 8 clusters as a reasonable data reduction method. These 8 clusters were then used to define patient states in a tabular reinforcement learning model trained on 80% of dosing decisions. Testing of this model on the remaining 20% of dosing decisions revealed good accuracy of the reinforcement learning model, with only 16/410 (3.9%) instances of disagreement. CONCLUSIONS: Dose adjustments are a strong determinant of whether patients are able to successfully initiate dofetilide. A reinforcement learning algorithm informed by unsupervised learning was able to predict dosing decisions with 96.1% accuracy. Future studies will apply this algorithm prospectively as a data-driven decision aid.
format Online
Article
Text
id pubmed-6938356
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69383562020-01-07 Applications of machine learning in decision analysis for dose management for dofetilide Levy, Andrew E. Biswas, Minakshi Weber, Rachel Tarakji, Khaldoun Chung, Mina Noseworthy, Peter A. Newton-Cheh, Christopher Rosenberg, Michael A. PLoS One Research Article BACKGROUND: Initiation of the antiarrhythmic medication dofetilide requires an FDA-mandated 3 days of telemetry monitoring due to heightened risk of toxicity within this time period. Although a recommended dose management algorithm for dofetilide exists, there is a range of real-world approaches to dosing the medication. METHODS AND RESULTS: In this multicenter investigation, clinical data from the Antiarrhythmic Drug Genetic (AADGEN) study was examined for 354 patients undergoing dofetilide initiation. Univariate logistic regression identified a starting dofetilide dose of 500 mcg (OR 5.0, 95%CI 2.5–10.0, p<0.001) and sinus rhythm at the start of dofetilide loading (OR 2.8, 95%CI 1.8–4.2, p<0.001) as strong positive predictors of successful loading. Any dose-adjustment during loading (OR 0.19, 95%CI 0.12–0.31, p<0.001) and a history coronary artery disease (OR 0.33, 95%CI 0.19–0.59, p<0.001) were strong negative predictors of successful dofetilide loading. Based on the observation that any dose adjustment was a significant negative predictor of successful initiation, we applied multiple supervised approaches to attempt to predict the dose adjustment decision, but none of these approaches identified dose adjustments better than a probabilistic guess. Principal component analysis and cluster analysis identified 8 clusters as a reasonable data reduction method. These 8 clusters were then used to define patient states in a tabular reinforcement learning model trained on 80% of dosing decisions. Testing of this model on the remaining 20% of dosing decisions revealed good accuracy of the reinforcement learning model, with only 16/410 (3.9%) instances of disagreement. CONCLUSIONS: Dose adjustments are a strong determinant of whether patients are able to successfully initiate dofetilide. A reinforcement learning algorithm informed by unsupervised learning was able to predict dosing decisions with 96.1% accuracy. Future studies will apply this algorithm prospectively as a data-driven decision aid. Public Library of Science 2019-12-31 /pmc/articles/PMC6938356/ /pubmed/31891645 http://dx.doi.org/10.1371/journal.pone.0227324 Text en © 2019 Levy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Levy, Andrew E.
Biswas, Minakshi
Weber, Rachel
Tarakji, Khaldoun
Chung, Mina
Noseworthy, Peter A.
Newton-Cheh, Christopher
Rosenberg, Michael A.
Applications of machine learning in decision analysis for dose management for dofetilide
title Applications of machine learning in decision analysis for dose management for dofetilide
title_full Applications of machine learning in decision analysis for dose management for dofetilide
title_fullStr Applications of machine learning in decision analysis for dose management for dofetilide
title_full_unstemmed Applications of machine learning in decision analysis for dose management for dofetilide
title_short Applications of machine learning in decision analysis for dose management for dofetilide
title_sort applications of machine learning in decision analysis for dose management for dofetilide
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938356/
https://www.ncbi.nlm.nih.gov/pubmed/31891645
http://dx.doi.org/10.1371/journal.pone.0227324
work_keys_str_mv AT levyandrewe applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide
AT biswasminakshi applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide
AT weberrachel applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide
AT tarakjikhaldoun applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide
AT chungmina applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide
AT noseworthypetera applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide
AT newtonchehchristopher applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide
AT rosenbergmichaela applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide